<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336505">
  <stage>Registered</stage>
  <submitdate>7/02/2011</submitdate>
  <approvaldate>8/02/2011</approvaldate>
  <actrnumber>ACTRN12611000144910</actrnumber>
  <trial_identification>
    <studytitle>Quantifying the effect of the sedative alprazolam on brain electrical activity using the Brain Anaesthesia Response monitor</studytitle>
    <scientifictitle>Quantifying the effect of alprazolam on brain electrical activity in healthy males using the BAR monitor</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anaesthetic depth using processed electroencephalography</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Single 1 mg oral alprazolam dose</interventions>
    <comparator>resting EEG prior to drug treatment</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in BAR index (mean pole location)</outcome>
      <timepoint>BAR index recorded for 5 minutes every hour for 3 hours following drug administration</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes from baseline in relative delta, theta, alpha, beta and gamma power will be assessed using repeated measures ANOVA.</outcome>
      <timepoint>Assessed every hour for 3 hours following drug administration</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>non-smoker, no history of anxiety, depression or other psychiatric disorder, no history of epilepsy or other neurological disorder known to affect resting EEG</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>consumption of any pharmaceutical product/medicine in last 30 days, consumption of vitamin complex or herbal extract withion last 30 days, history of alcohol or drug abuse</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/02/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Swinburne University of Technology</primarysponsorname>
    <primarysponsoraddress>P.O. Box 218
Hawthorn VIC 3122</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Cortical Dynamics Ltd</fundingname>
      <fundingaddress>14 View St
North Perth WA 6006</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is designed to evaluate a new method for monitoring the effects of sedatives on the brain's electrical activity. The method involves a sophisticated, physiologically motivated, algorithm for the analysis of the scalp recorded electroencephalogram.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor David TJ Liley</name>
      <address>Brain and Psychological Sciences Research Centre
Swinburne University of Technology
P.O. Box 218
Hawthorn VIC 3122</address>
      <phone>+61 3 9124 8812</phone>
      <fax />
      <email>dliley@swin.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor David TJ Liley</name>
      <address>Brain and Psychological Sciences Research Centre
Swinburne University of Technology
P.O. Box 218
Hawthorn VIC 3122</address>
      <phone>+61 3 9214 8812</phone>
      <fax />
      <email>dliley@swin.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor David TJ Liley</name>
      <address>Brain and Psychological Sciences Research Centre
Swinburne University of Technology
P.O. Box 218
Hawthorn VIC 3122</address>
      <phone>+61 3 9124 8812</phone>
      <fax />
      <email>dliley@swin.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>